Price $75.00 |
Market Cap
39.02B
|
Sector Health Care |
Div. Growth
23.10%
|
|
P/E
28.5
|
P/B
4.37
|
P/S
3.7
|
Dividend %
1.00%
|
|
P/CF
487.2
|
P/FCF
37.2
|
Op. Cash Flow
2.1M
|
FCF
1.9
|
|
Op. Margin
12.80%
|
Net Margin
7.70%
|
ROE
9.00%
|
ROI
10.90%
|
|
ROA
4.90%
|
EPS Growth
-54.80%
|
Current Ratio
2.6
|
Debt/Equity
38.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.25 | - | - | 40.1M | Strong Buy |
| Reliv International, Inc (RELV) | $4.82 | - | - | 8.9M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $22.93 | - | 3.50% | 24.52B | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.95 | - | - | 60.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
